Abhay Joshi - Mar 15, 2022 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Signature
/s/ Terri McDowell, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Mar 15, 2022
Transactions value $
-$41,165
Form type
4
Date filed
3/17/2022, 05:56 PM
Previous filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Tax liability -$41.2K -2.61K -2.11% $15.79 121K Mar 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award (the "RSA") for 22,620 shares. The RSA vests in three equal annual installments from March 15, 2021, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.